HOME
|
COMPANY
Overview
Corporate Strategy
Management
Careers
|
PRODUCTS
Overview
Amytal
®
Sodium
Opium Tincture
Seconal Sodium
®
|
CLINICAL DEVELOPMENT
|
BUSINESS DEVELOPMENT
Overview
Product Acquisitions
Strategic Partnerships
|
PRESS
|
CONTACT
Site Map
Home
COMPANY
Overview
Corporate Strategy
Management
Robert Altman, President
Tim Ackerman, Director, Commercial Assessment
James A. Sharples, Director, Marketing
Dan Peisert, Director, Finance
Careers
PRODUCTS
Overview
Amytal
®
Sodium
Opium Tincture
Seconal Sodium
®
CLINICAL DEVELOPMENT
Overview
BUSINESS DEVELOPMENT
Overview
Product Acquisitions
Strategic Partnerships
PRESS
Amytal
®
Sodium Available
January 30, 2009
Seconal
®
Sodium Available
January 30, 2009
Opium Tincture Launched
October 27, 2008
Three Products Acquired
September 27, 2008
CONTACT